Pharvaris announces acceptance of abstracts for upcoming congresses, showcasing research on oral bradykinin B2 receptor antagonists and angioedema.

Selected for Rapid Fire Presentation: Quick preview poster presentation on a multimedia display to allow meeting attendees to further engage with the presenters at their paper poster.

Presentation of an abstract related to Naveris' flagship diagnostic test, NavDx®, at the ASCO 2022 annual meeting.